Vicore Pharma Holding AB (VCRE) — research page
US · us-cm-kg/NASDAQ/VCRE · as of 2026-11-08
Identity and listing
The issuer is Vicore Pharma Holding AB, listed on NASDAQ under ticker VCRE, with ISIN US92581R1041. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-V7. The security type is non-operating entity type (other), sector 2834 Pharmaceutical Preparations, jurisdiction Sweden, and segment not on the record. The issuer is listed and not halted.
| field | value | source · read date |
|---|---|---|
| name | Vicore Pharma Holding AB | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | VCRE | source · 2026-11-08 |
| ISIN | US92581R1041 | source · 2026-10-14 |
| LEI | not on the record | |
| security type | Non-operating entity type (other) | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2834 Pharmaceutical Preparations | source · 2026-11-08 |
| jurisdiction | Sweden | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 13 filings in the window 2025-11-08 to 2026-11-08, across 11 filing days, of which 7 are regulatory filings and 6 are results. The median gap between filing days is 15.5 days. The latest filing is dated 2026-11-05, a results filing, 3 days before the record date of 2026-11-08. On NASDAQ the median cadence gap is 6.0 days, the median filings count is 52, and the median latency is 5.0 days across 4359 issuers. In sector 2834 Pharmaceutical Preparations the median cadence gap is 6.0 days, the median filings count is 63.0, and the median latency is 4.0 days across 526 issuers.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 13 | 15.5 | 3 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2834 Pharmaceutical Preparations (526 issuers) | 63 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-05 | results | 6-K | 6-K — FORM 6-K |
| 2026-11-03 | results | 6-K | 6-K — FORM 6-K |
| 2026-10-22 | results | 6-K | 6-K — FORM 6-K |
| 2026-10-13 | regulatory_filing | SCHEDULE 13G | SCHEDULE 13G |
| 2026-09-30 | results | 6-K | 6-K — FORM 6-K |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is not on the record, as the latest annual report cover carries no dei:AuditorName tag, and the auditor's location is not on the record. The record holds no auditor changes.
Events and halts
The record holds one lifecycle line, a listing dated 2026-06-30. It holds no delisting, name change, or domicile change, and the segment move is not on the record. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The halt flag reads listed, not halted.
Orderability
The orderability outcome is not determinable, as the chapter's orderability section carries no client categories and the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The record finds 11 research houses named on the issuer's investor-relations page: ABG Sundal Collier, Cantor, Danske Bank, DNB Carnegie, Guggenheim, Jefferies, Pareto Securities, Stifel, Van Lanschot Kempen, Arctic Securities, and Chardan.
| research house | analyst | source · read date |
|---|---|---|
| ABG Sundal Collier | Georg Tigalonov-Bjerke | issuer page · 2026-11-11 |
| Cantor | Steve Seedhouse | issuer page · 2026-11-11 |
| Danske Bank | Gonzalo Artiach | issuer page · 2026-11-11 |
| DNB Carnegie | Arvid Necander | issuer page · 2026-11-11 |
| Guggenheim | Vamil Divan | issuer page · 2026-11-11 |
| Jefferies | Faisal Khurshid | issuer page · 2026-11-11 |
| Pareto Securities | Chien-Hsun Lee | issuer page · 2026-11-11 |
| Stifel | Clemence Thiers | issuer page · 2026-11-11 |
| Van Lanschot Kempen | Sushila Hernandez | issuer page · 2026-11-11 |
| Arctic Securities | Gasper Virant | issuer page · 2026-11-11 |
| Chardan | Andreas Argyrides | issuer page · 2026-11-11 |
Open research
The record holds one openly published research note, by Goetzpartners Healthcare Research, dated 2018-03-22.
| date | publisher | note | kind |
|---|---|---|---|
| 2018-03-22 | Goetzpartners Healthcare Research | Novel approach to tackle fibrotic orphan diseases | issuer-sponsored |
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The sealed years that hold the issuer are 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12.
Sources
9 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0002124403.json (identity.jurisdiction)
- 10.4
- https://mcp.us-cm-kg.ai/events/NASDAQ/VCRE (the disclosure lines)
- 10.5
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.6
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.7
- https://vicorepharma.com/investerare/aktieinformation-2/analytiker/ (coverage)
- 10.8
- http://vicorepharma.com/wp-content/uploads/2019/06/goetz-partners-vph-180322.pdf (open research)
- 10.9
- https://mcp.us-cm-kg.ai/record/NASDAQ/VCRE (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"US92581R1041"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:ee4f12127b721ee6.